Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Apr 10, 2026
Aehr Test Systems (AEHR): +63% Surge in 30 Days on AI-Driven Bookings Momentum

Aehr Test Systems (AEHR): +63% Surge in 30 Days on AI-Driven Bookings Momentum

Key Takeaways

  • AEHR stock surged +63% over the past 30 days amid record bookings of $37.2 million driven by AI data center and silicon photonics demand.
  • Over the past quarter, shares climbed +160%, reflecting strong order momentum from hyperscale customers despite softer revenue.
  • Major catalysts include multi-million-dollar orders for wafer-level burn-in systems testing AI processors and optical interconnects.
  • Record effective backlog of $50.9 million signals robust future revenue, boosting investor sentiment in the semiconductor test equipment sector.
  • Company reaffirmed high-end fiscal 2026 guidance, with bookings expected at the upper range of $60-80 million for the second half.

Understanding Aehr Test Systems (AEHR) and Its Market Position

Aehr Test Systems (AEHR), based in Fremont, California, stands out as a key player in semiconductor test and burn-in equipment. The company focuses on solutions that test, burn-in, and stabilize devices at the wafer level, singulated die, and package part form factors. Its flagship products—the FOX-XP and FOX-P series systems, WaferPak contactors, and DiePak carriers—support high-throughput testing for cutting-edge semiconductors.

From what I see, Aehr's revenue model benefits from both system sales and high-margin recurring consumables like WaferPaks and DiePaks. It maintains a solid foothold in fast-growing areas such as silicon carbide (SiC) power devices for electric vehicles (EVs), gallium nitride (GaN), silicon photonics for data centers, and AI processors. This positioning in critical applications for AI infrastructure, EVs, and telecom has driven much of the recent stock movement, as demand for reliable, high-power semiconductors picks up.

AEHR Stock Performance: Breaking Down the Last 30 Days and Quarter

In the last 30 days, AEHR stock climbed +63%, moving from a closing price of about $42 to $68. The path was volatile but trend-driven, with notable gains in early April tied to earnings and order news, including a 26% single-day spike on April 8.

Looking at the past quarter, shares advanced +160%, from roughly $26 to $68. This period showed steady uptrends with occasional dips, like in late March, but overall momentum built on a stream of positive developments in semiconductor testing.

Key Drivers Behind AEHR's 30-Day Rally

The recent 30-day surge came after Aehr's fiscal third-quarter results on April 7, which posted record bookings of $37.2 million and a book-to-bill ratio over 3.5x, largely from AI and data center demand. A standout was a major silicon photonics order from a global networking leader for high-power FOX-XP systems aimed at hyperscale data center optical interconnects. Even with revenue at $10.3 million missing estimates due to shipment timing, the $50.9 million effective backlog drew strong investor interest.

Prior announcements, such as the March 31 follow-on order for AI optical I/O systems, added to the positive sentiment. Analyst moves like Lake Street raising its price target to $56 while keeping a Buy rating helped fuel the rally. In my view, sector tailwinds in AI semiconductor testing have overshadowed any softness in the EV market affecting SiC demand. I also checked this using Tickeron’s AI Screener to compare AEHR against peers in the industry.

What Fueled AEHR's Strong Quarterly Performance

The quarterly gain was built on a series of significant orders that underscore Aehr's importance in AI infrastructure. Highlights included a $14 million February order from a leading AI processor customer for FOX-XP systems, a February production win for Sonoma systems testing next-gen ASICs, and January's $5.5 million Sonoma orders for AI processors.

These AI and data center themes have largely eclipsed revenue dips from EV-related SiC weakness and technical delays. Institutional buying aligned with broader trends in high-performance computing and photonics, helping shares break out during the semiconductor recovery. The growing cumulative backlog points to solid long-term prospects in power semiconductors and telecom.

Trending AI Robots

In my research, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI trading bots out of hundreds available. These bots scan thousands of tickers using strategies like trend-following, mean reversion, and momentum, across timeframes from intraday to long-term swings. They provide key metrics such as win rate, profit factor, and Sharpe ratio, with a focus on recent outperformance in volatile sectors like semiconductors. One thing that stands out is how these tools help refine analysis and automate decisions with data-driven insights—I've found them particularly useful for tracking momentum plays like AEHR.

What's Next for AEHR: Key Forecast Drivers to Watch

Looking ahead, I'm watching the fiscal fourth-quarter earnings closely for updates on backlog conversion and margin recovery. Important trends include AI accelerator rollouts, silicon photonics growth in data centers, and potential SiC/GaN rebound as EV demand stabilizes. Broader factors like interest rates and chip supply chains could sway hyperscaler spending.

Positive developments might come from ramped Sonoma production capacity—now over 20 systems per month—and new qualifications in memory or power semis. Risks remain, including order variability, competition from companies like TER, and meeting guidance. Much of the sentiment will depend on returning to non-GAAP profitability in Q4 fiscal 2026.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: AEHR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AEHR's Stochastic Oscillator is staying in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for AEHR crossed bullishly above the 50-day moving average on August 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 247 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AEHR moved out of overbought territory on August 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AEHR turned negative on August 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at .

AEHR moved below its 50-day moving average on August 26, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AEHR broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock slightly better than average.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.005) is normal, around the industry mean (7.461). P/E Ratio (19.449) is within average values for comparable stocks, (140.036). AEHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.384). AEHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (49.505) is also within normal values, averaging (29.294).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 61.11B. The market cap for tickers in the group ranges from 555.66K to 668.82B. ASML holds the highest valuation in this group at 668.82B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was -7%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 14%. IPGP experienced the highest price growth at 4%, while SMTK experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 28%. For the same stocks of the Industry, the average monthly volume growth was -43% and the average quarterly volume growth was -37%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 37
Price Growth Rating: 47
SMR Rating: 73
Profit Risk Rating: 68
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
AEHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of burn-in and test equipment for semiconductor manufacturing

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
400 Kato Terrace
Phone
+1 510 623-9400
Employees
136
Web
https://www.aehr.com
Interact to see
Advertisement
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
Coherent Corp (COHR) has surged 200%+ over the past year and 35% YTD, fueled by AI datacenter demand and strong Q2 fiscal 2026 results (17% YoY revenue growth). QUALCOMM Incorporated (QCOM) trades at a reasonable PE of 29x with 15% YTD gains, but memory shortages have constrained handset sales, partially offset by growth in data center chips. Taiwan Semiconductor Manufacturing Company Limited (TSM) leads with 96% one-year returns and 28% YTD, supported by record AI chip sales and projected 53.8% quarterly earnings growth.
RIME (Algorhythm Holdings Inc.) is up more than 24% today mainly because its SemiCab unit landed a high‑profile pilot with Coca‑Cola’s largest bottling partner in India, reinforcing bullish sentiment around its AI freight platform and sparking aggressive retail and momentum buying in a thinly traded penny stock.
GDDY (GoDaddy) is down more than 17% today because its 2026 revenue outlook and near‑term sales guidance came in below Wall Street expectations, reinforcing worries about slowing growth and intense AI‑driven competition even though Q4 2025 headline results were solid.
For the first half of fiscal 2026, organic net sales and adjusted EPS both declined about 3% year over year and missed analyst expectations, with U.S. spirits and Chinese white spirits particularly weak. Management cut full‑year 2026 guidance again, now expecting organic sales to fall 2–3% and organic operating profit to be flat to up only low single digits, versus a prior outlook of flat to slightly down sales and low‑ to mid‑single‑digit profit growth.
DRVN (Driven Brands) is down more than 36% today because the company disclosed serious errors in its past financial statements, is delaying its Q4 2025 earnings release, and will have to restate results for the last two fiscal years, which shattered investor confidence and raised concerns about leverage and profitability.
Q4 2025 revenue was strong at about 257–258 million (up roughly 16% year over year and above forecasts), but adjusted EPS was 0.30 versus about 0.31–0.32 expected, and EBITDA of about 101–102 million was a touch below consensus.